UK markets open in 50 minutes

Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
91.40+0.36 (+0.40%)
At close: 04:03PM EDT
91.88 +0.48 (+0.53%)
After hours: 07:56PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
16,579,000
13,049,000
7,067,000
9,843,000
6,220,000
Depreciation & amortisation
3,652,000
3,214,000
3,625,000
3,652,000
4,519,000
Deferred income taxes
-442,000
187,000
-668,000
-556,000
-509,000
Stock-based compensation
493,000
479,000
475,000
417,000
348,000
Change in working capital
-2,882,000
-3,839,000
-4,590,000
-2,067,000
-1,553,000
Accounts receivable
-
-2,033,000
-1,002,000
294,000
-418,000
Inventory
-
-674,000
-855,000
-508,000
-911,000
Accounts payable
-
405,000
724,000
399,000
230,000
Other working capital
14,398,000
9,661,000
5,569,000
9,967,000
8,307,000
Other non-cash items
1,253,000
2,361,000
2,611,000
1,177,000
1,628,000
Net cash provided by operating activities
18,891,000
14,109,000
10,253,000
13,440,000
10,922,000
Cash flows from investing activities
Investments in property, plant and equipment
-4,493,000
-4,448,000
-4,684,000
-3,473,000
-2,615,000
Acquisitions, net
-11,263,000
-12,907,000
-6,606,000
-4,954,000
-431,000
Purchases of investments
-705,000
-1,000
-1,095,000
-3,202,000
-7,994,000
Sales/maturities of investments
1,014,000
1,026,000
2,812,000
8,622,000
15,252,000
Other investing activities
87,000
-91,000
130,000
378,000
102,000
Net cash used for investing activities
-15,360,000
-16,555,000
-9,443,000
-2,629,000
4,314,000
Cash flows from financing activities
Debt repayment
-2,416,000
-2,319,000
-1,957,000
0
-4,287,000
Common stock repurchased
-601,000
-840,000
-1,281,000
-4,780,000
-9,091,000
Dividends paid
-6,807,000
-6,610,000
-6,215,000
-5,695,000
-5,172,000
Other financing activities
-299,000
8,714,000
-436,000
5,000
-325,000
Net cash used provided by (used for) financing activities
-1,930,000
3,097,000
-2,832,000
-8,861,000
-13,160,000
Net change in cash
1,123,000
14,000
-1,769,000
1,967,000
1,871,000
Cash at beginning of period
8,630,000
8,153,000
9,934,000
7,967,000
6,096,000
Cash at end of period
10,231,000
8,167,000
8,165,000
9,934,000
7,967,000
Free cash flow
Operating cash flow
18,891,000
14,109,000
10,253,000
13,440,000
10,922,000
Capital expenditure
-4,493,000
-4,448,000
-4,684,000
-3,473,000
-2,615,000
Free cash flow
14,398,000
9,661,000
5,569,000
9,967,000
8,307,000